Illness IT Provider Supply Chain 
FDA Law Blog
SEPTEMBER 16, 2024
Innovative manufacturing” is a somewhat ill-defined term, but the agency uses it to refer to any novel manufacturing that can increase product development speed, bolster supply chains, or prevent drug shortages. It was at this workshop that the agency committed to issuing a draft strategy document, for public comment.
FDA Law Blog
NOVEMBER 22, 2022
Gaulkin — At the risk of ruining our readers’ appetite for America’s most food-focused holiday, foodborne illnesses have been a feature of Thanksgiving for some time now. When foodborne illness outbreaks arise, efficient traceability is critical to prevent illnesses, death, and unnecessary product loss.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BMJ
AUGUST 20, 2021
In the United Kingdom (UK), primary care practitioners are the first-line clinicians which most patients encounter, providing initial assessment and treatment of a wide variety of conditions. Over one billion prescriptions per year are signed in the UK by these general practitioners (GPs) in primary care.
GeriPal
SEPTEMBER 14, 2023
If you are interested in learning more and meeting a community of folks interested in hospital-at-home, check out the hospital-at-home user group at hahusersgroup.org or some of these publications: Hospital-Level Care at Home for Acutely Ill Adults: A Randomized Controlled Trial. How is it financed and what comes next? Annals of Int Med.
FDA Law Blog
JANUARY 9, 2024
This request must provide details about, among other things: The foreign seller that will purchase the prescription drug directly from its manufacturer, along with invoices, batch, and lot/control numbers to verify the sale and the units sold. More Steps Ahead As the SIP sponsor, Florida will be responsible for implementing the program.
Expert insights. Personalized for you.
59 
Let's personalize your content